Adults who have a diagnosis of moderate to severe plaque psoriasis (plaque PsO) may qualify for this clinical research trial and receive investigational oral medication vs subcutaneous injection.
- Age: ≥ 18
- BSA ≥ 10-15%, PASI ≥ 12, sPGA = 3
- Diagnosis of Plaque PsO within the past 6 months
- Documented history of an inadequate topical response failure of systemic therapies
Patients will be asked to visit the clinic about 10 times over approximately 70 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.
For further information on the study, please follow the link:
Trial ID: NCT06333860
If you are interested and would like to participate in this trial, please register your details and answer a few short questions for our recruitment team to back to you: eligibility questionnaire